FUL is running its best stretch in months — up 10.9% over the past 30 days and 5.3% on the week alone — yet options positioning suggests investors are hedging more than celebrating.
The most striking data point this week is in the options market. Put/call ratio has climbed to 2.08, well above its 20-day average of 1.83, and has been running above 2.0 for most of the past two weeks. That's a notable shift from early July, when the ratio sat comfortably below 1.2. The move reflects heavier demand for downside protection even as the stock rallies — a divergence worth watching into the September 23 earnings date. The ratio is still far from the 52-week high of 6.24, so this reads as cautious hedging rather than outright bearishness.
Short interest adds nuance. Bears rebuilt positions meaningfully on August 11 — short interest jumped 15.7% in a single session to 4.6% of the free float, the sharpest one-day move in the 30-day window. That said, 4.6% is not an extreme level for a specialty chemicals name, and the lending market is nowhere near stressed. Borrow availability is running at roughly 12x the current short interest — about 37.8 million shares available against 2.5 million shorted — with borrowing costs near their 30-day lows at 0.37%. The short-interest rebuild looks more like momentum-chasing on a rising stock than a conviction bear trade. The ORTEX short score has also drifted lower over the past week, from 44 on July 30 to 40 today, consistent with shorts losing ground rather than gaining it.
The Street has been broadly constructive, though the most recent analyst actions date to late June and are outside the two-week window for fresh bellwether commentary. What was notable then: JPMorgan upgraded FUL to Overweight, Citigroup nudged its Buy target to $75, and Deutsche Bank lifted its target to $72 — all after the Q2 print. The consensus mean target now implies roughly 18% upside from the current price of $62.03. Valuation has moved alongside the stock: the P/E multiple is up about one full turn over 30 days, now at 12.1x, and price-to-book has risen from roughly 1.32 to 1.45. EV/EBITDA at 7.7x remains modest for the sector. Factor scores are mixed — EV/EBIT ranks in the 61st percentile, but forward EPS growth scores only in the 30th, a reminder that the re-rating has been driven by sentiment and multiple expansion, not an acceleration in earnings estimates.
The peer picture amplifies FUL's outperformance. AVNT surged 19.1% on the week — an outlier likely driven by company-specific news — while RPM was up just 1.4% and PPG slipped 1.4%. IOSP added 8.4%, making it the only other name keeping pace with FUL's move. Specialty chemicals broadly had a quiet week, which makes FUL's 5.3% gain stand out rather than reflect a sector-wide tailwind.
On the ownership side, Neuberger Berman is the standout institutional move in recent filings — the firm reported a near-complete new position of 1.39 million shares, representing roughly 2.6% of the company. BlackRock, already the largest holder at 15.5% of shares, added a further 280,000 shares in July. Both additions came as the stock was recovering from its post-earnings weakness in late June, when it fell roughly 2% on the day and a further 10% over the following five sessions. With the September 23 earnings date on the calendar, that post-print pattern — and whether the current multiple expansion has priced in a recovery — becomes the central question to track.
See the live data behind this article on ORTEX.
Open FUL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
